<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="174446">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00824915</url>
  </required_header>
  <id_info>
    <org_study_id>MDT1623319</org_study_id>
    <nct_id>NCT00824915</nct_id>
  </id_info>
  <brief_title>Enhanced Surveillance of RV Lead Integrity Alert (RVLIA)</brief_title>
  <acronym>RVLIA</acronym>
  <official_title>Enhanced Surveillance of RV Lead Integrity Alert (RVLIA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to prospectively monitor the performance of the RV Lead Integrity Alert (LIA)
      upon commercial release.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of the LIA algorithm</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive predictive value of the LIA algorithm</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of false positives per patient-year of the LIA algorithm</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in the percent of patients with the LIA algorithm with an RV lead fracture who receive at least one inappropriate shock</measure>
    <time_frame>Event driven (analysis requires 50 events)</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1779</enrollment>
  <condition>Shock</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a confirmed Lead Integrity Algorithm download with a device download within
        the open and closed date of data collection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lead Integrity Algorithm download; requires a Medtronic device that supports the LIA
             algorithm; requires an RV lead; selected as part of the identified cohort

        Exclusion Criteria:

          -  A device that does not support the Lead Integrity Algorithm,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RVLIA Trial Leader</last_name>
    <role>Study Chair</role>
    <affiliation>Medtronic</affiliation>
  </overall_official>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 24, 2013</lastchanged_date>
  <firstreceived_date>January 16, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lead Integrity Algorithm</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
